Figure 2.
The clinical course of afatinib treatment. The dose of afatinib was reduced twice to relieve adverse clinical events. The patient currently receives afatinib (20 mg/day).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.